Janux Therapeutics Inc (NASDAQ:JANX) traded at $56.08 at close of the session on Monday, April 29, made an upward move of 18.34% on its previous day’s price.
Looking at the stock we see that its previous close was $47.39. In terms of its 52-week price range, JANX has a high of $58.69 and a low of $5.65. The company’s stock has gained about 48.95% over that past 30 days.
Janux Therapeutics Inc has a market cap of $2.90 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.33, with the EPS growth for the year raised at -$1.35 for 2024 and -$1.64 for next year. These figures represent -2.30% and -21.50% growth in EPS for the two years respectively.
The median projection represents growth adding up to -62.90% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $2.76 million, or -65.90% down from figures reported last year.
On the other hand, looking at the outlook for the JANX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 25.23% off its SMA20 and 45.39% from its 50-day simple moving average. The RSI (14) is pointing at 72.96 while the volatility over the past week is 9.94% and jumps to 9.31% over the past one month. The beta value is 4.07, while the average true range (ATR) is currently pointing at 4.30.
Coming back to Janux Therapeutics Inc (NASDAQ:JANX), we note that the average 3-month trading volume was 941.25K. Current shares outstanding are 46.25 million.
The insiders hold 33.35% of the company’s shares while institutions hold 57.73%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 422.65% up in year-to-date price movement.
